These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19755321)

  • 21. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
    Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
    Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymers, drug release, and drug-eluting stents.
    Commandeur S; van Beusekom HM; van der Giessen WJ
    J Interv Cardiol; 2006 Dec; 19(6):500-6. PubMed ID: 17107364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
    Kedia G; Lee MS
    Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
    Kamath KR; Barry JJ; Miller KM
    Adv Drug Deliv Rev; 2006 Jun; 58(3):412-36. PubMed ID: 16647782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.
    Nordmann AJ; Briel M; Bucher HC
    Eur Heart J; 2006 Dec; 27(23):2784-814. PubMed ID: 17020889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stents: results, promises and problems.
    van der Hoeven BL; Pires NM; Warda HM; Oemrawsingh PV; van Vlijmen BJ; Quax PH; Schalij MJ; van der Wall EE; Jukema JW
    Int J Cardiol; 2005 Mar; 99(1):9-17. PubMed ID: 15721493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new wave in treatment of vascular occlusive disease: biodegradable stents--clinical experience and scientific principles.
    Brown DA; Lee EW; Loh CT; Kee ST
    J Vasc Interv Radiol; 2009 Mar; 20(3):315-24; quiz 325. PubMed ID: 19157901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents.
    Thanigaraj S; Wollmuth JR; Zajarias A; Chemmalakuzhy J; Lasala JM
    Coron Artery Dis; 2006 Dec; 17(8):673-9. PubMed ID: 17119375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis.
    Vaina S; Ong AT; Serruys PW
    Minerva Cardioangiol; 2005 Oct; 53(5):341-60. PubMed ID: 16179880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.
    Kumbhani DJ; Bavry AA; Kamdar AR; Helton TJ; Bhatt DL
    Am Heart J; 2008 Apr; 155(4):640-7. PubMed ID: 18371470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of drug-eluting stents: impact of French recommendations on the rate of clinical restenosis at 2 years].
    Mboup MC; Moquet B; Zabalawi A; Delaunay R
    Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):88-92. PubMed ID: 22436635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer.
    Abizaid A; Costa JR; Feres F
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):49-51. PubMed ID: 20506126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary stents: looking forward.
    Garg S; Serruys PW
    J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S43-78. PubMed ID: 20797503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of current devices and a look at new technology: drug-eluting stents.
    Nakazawa G; Finn AV; Kolodgie FD; Virmani R
    Expert Rev Med Devices; 2009 Jan; 6(1):33-42. PubMed ID: 19105778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of drug-eluting stents.
    Räber L; Windecker S
    Cardiovasc Ther; 2011 Jun; 29(3):176-89. PubMed ID: 20370793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?
    Ryan J; Cohen DJ; Pinto DS
    Coron Artery Dis; 2006 Dec; 17(8):667-71. PubMed ID: 17119374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-eluting stents and stent thrombosis: a cause for concern?
    Wernick MH; Jeremias A; Carrozza JP
    Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.